Guardant Health GH International — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Guardant Health in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Guardant Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Guardant Health's international — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Guardant Health's international — revenue?
- Guardant Health (GH) reported international — revenue of $17.04M in Q1 2026.
- How has Guardant Health's international — revenue changed year-over-year?
- Guardant Health's international — revenue increased by 72.7% year-over-year, from $9.86M to $17.04M.
- What is the long-term trend for Guardant Health's international — revenue?
- Over 4 years (2021 to 2025), Guardant Health's international — revenue has grown at a 29.2% compound annual growth rate (CAGR), from $21.09M to $58.74M.
- What does international — revenue mean?
- This metric represents the total gross revenue generated from sales and services provided to customers located outside of the company's primary domestic market. It reflects the company's success in expanding its diagnostic testing footprint, navigating local regulatory environments, and establishing commercial partnerships in global territories. Growth in this segment is a key indicator of the company's ability to scale its liquid biopsy platform beyond its home market.